A preliminary evaluation of efficacy and safety of Wharton’s jelly mesenchymal stem cell transplantation in patients with type 2 diabetes mellitus

INTRODUCTION: Stem cell therapy has recently been introduced to treat patients with type 2 diabetes mellitus (T2DM). However, no data are available on the efficacy and safety of allogeneic Wharton’s Jelly-derived mesenchymal stem cell (WJ-MSC) transplantation in patients with T2DM. Here we performed...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Xuebin, Zheng, Pei, Wang, Xiaodong, Dai, Guanghui, Cheng, Hongbin, Zhang, Zan, Hua, Rongrong, Niu, Xinxin, Shi, Jing, An, Yihua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4055092/
https://www.ncbi.nlm.nih.gov/pubmed/24759263
http://dx.doi.org/10.1186/scrt446

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4055092/
https://www.ncbi.nlm.nih.gov/pubmed/24759263
http://dx.doi.org/10.1186/scrt446

Ejemplares similares